Andrew Korytko | Lead External Innovation, Biotechnology Discovery Research
Eli Lilly and Company

Andrew Korytko, Lead External Innovation, Biotechnology Discovery Research, Eli Lilly and Company

Dr. Andrew Korytko is currently group leader in protein engineering at Eli Lilly and Company. He has been with Eli Lilly since 2004 and previously was at Applied Molecular Evolution for a number of years before it became a part of Eli Lilly in 2004. Dr. Korytko has over 25 years of experience in research and development in protein engineering and molecular evolution.

Appearances:



FOB SD Antibodies Day 1 @ 11:30

Plenary roundtable session

12 senior level tables hosted by thought leaders on key challenges and opportunities in antibody drug discovery and development. Participants are invited to join the group discussions on a topic of importance to them. The round table session will have two rotations, each lasting 30 minutes.

Table 1: Protein engineering

last published: 16/Nov/18 16:35 GMT

back to speakers